SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-167148
Filing Date
2020-06-12
Accepted
2020-06-12 07:04:11
Documents
18
Period of Report
2020-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d935991d8k.htm   iXBRL 8-K 39188
2 EX-99.1 d935991dex991.htm EX-99.1 16230
3 EX-99.2 d935991dex992.htm EX-99.2 27240
4 EX-99.3 d935991dex993.htm EX-99.3 19017
8 GRAPHIC g935991g21l24.jpg GRAPHIC 3817
9 GRAPHIC g935991g97e21.jpg GRAPHIC 3303
10 GRAPHIC g935991img1.jpg GRAPHIC 8184
  Complete submission text file 0001193125-20-167148.txt   268089

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agio-20200611.xsd EX-101.SCH 3048
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20200611_lab.xml EX-101.LAB 17373
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20200611_pre.xml EX-101.PRE 10938
15 EXTRACTED XBRL INSTANCE DOCUMENT d935991d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 20958848
SIC: 2834 Pharmaceutical Preparations